ライフサイエンスコーパス: immunoglobulin-like

1 Here, we show that CR cells express the immunoglobulin-like adhesion molecule nectin1, whereas n

2 Nectin-1 is a member of a sub-family of immunoglobulin-like adhesion molecules and a component o

3 ne protein and member of a family of related immunoglobulin-like adhesion molecules, as a potential t

4 Here we genetically targeted a stretch of 14 immunoglobulin-like and fibronectin type 3 domains that

5 Prominent modulation of the leukocyte immunoglobulin-like and signalling lymphocyte activation

6 a string of globular domains including eight immunoglobulin-like and three fibronectin-like domains t

7 thymus and skin that encodes a protein with immunoglobulin-like and transmembrane domains.

8 Shp(180) exhibits an immunoglobulin-like beta-sandwich fold that has been rec

9 Domain N with an immunoglobulin-like beta-sandwich fold was attached to t

10 TEAD2 YBD adopts an immunoglobulin-like beta-sandwich fold with two extra he

11 uman UNC119 at 1.95-A resolution revealed an immunoglobulin-like beta-sandwich fold.

12 and consists of two beta-sheets that form an immunoglobulin-like beta-sandwich fold.

13 The mu3A C-terminal domain consists of an immunoglobulin-like beta-sandwich organized into two sub

14 tations, we have solved the structure of the immunoglobulin-like C1 domain of MyBP-C by X-ray crystal

15 '-D''-alpha1-alpha2 subdomain grafted on the immunoglobulin-like core of FaeG hosts the carbohydrate

16 The membrane-distal immunoglobulin-like D1 domain of JAM-A is required for h

17 res revealed a collagen-binding site in each immunoglobulin-like domain (D1 and D2).

18 sialylation of the N-glycans on the adjacent immunoglobulin-like domain (Ig5), and acidic residues on

19 efacept is a chimeric protein combining CD58 immunoglobulin-like domain 1 with human IgG1 Fc.

20 LT-1 extracellular domain, suggest that this immunoglobulin-like domain autonomously plays an as yet

21 The LigB immunoglobulin-like domain binds to the 17th to 27th exo

22 ular fragment of TLT-1 consists of a single, immunoglobulin-like domain connected to the platelet cel

23 lipoprotein remnant receptor family known as immunoglobulin-like domain containing receptor 1 (ILDR1)

24 ILDR1 encodes the evolutionarily conserved immunoglobulin-like domain containing receptor 1, a puta

25 LRIG1 (leucine-rich repeat and immunoglobulin-like domain containing), a member of the

26 hicken CAR, or with the heterologous type C2 immunoglobulin-like domain from IgSF11, another IgSF mem

27 engage a conserved hydrophobic groove in the immunoglobulin-like domain III (D3) of the "c" splice is

28 In this postfusion conformation, the immunoglobulin-like domain III (DIII) and the stem regio

29 d by six leucine-rich repeat domains and one immunoglobulin-like domain in their extracellular moieti

30 fate chains and a specific site on the first immunoglobulin-like domain of PTPsigma.

31 roteins are similar except for an additional immunoglobulin-like domain of the phi29 protein.

32 A single immunoglobulin-like domain of the T-cell receptor (varia

33 affecting a conserved residue in the second immunoglobulin-like domain of titin, was introduced in a

34 ranslational folding on the ribosome of this immunoglobulin-like domain.

35 to residues 71 to 289, a region including an immunoglobulin-like domain.

36 beta-propeller architecture and a C-terminal immunoglobulin-like domain.

37 l describes the aggregation of Titin I27, an immunoglobulin-like domain.

38 The hSC structure comprises five immunoglobulin-like domains (D1-D5) arranged as a triang

39 g site on the apical surface between the two immunoglobulin-like domains (D1D2) of the receptor and s

40 nal actin-binding domain and 24 filamin-type immunoglobulin-like domains (FLN) that form tail-to-tail

41 ure of the agrin-responsive first and second immunoglobulin-like domains (Ig1 and Ig2) of the MuSK ec

42 Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is a pan-ErbB nega

43 Here, we found that leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is highly expresse

44 receptor antagonist leucine-rich repeats and immunoglobulin-like domains 1 (Lrig1), for further study

45 in LRIG2, encoding leucine-rich repeats and immunoglobulin-like domains 2, a protein implicated in n

46 Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by

47 The ectodomain of MuSK comprises three immunoglobulin-like domains and a cysteine-rich domain (

48 t has not been reported in tandem repeats of immunoglobulin-like domains and that is presumably conse

49 riant of human peroxidasin 1 comprising four immunoglobulin-like domains and the catalytically active

50 All methods indicate that the extracellular immunoglobulin-like domains are monomeric in solution an

51 ke related immune receptors, GPVI contains 2 immunoglobulin-like domains arranged in a perpendicular

52 mbrane glycoprotein, with four extracellular immunoglobulin-like domains containing three intrachain

53 in malignant transformation, we removed two immunoglobulin-like domains from the extracellular domai

54 A number of beta-sandwich immunoglobulin-like domains have been shown to fold usin

55 Tandem arrays of immunoglobulin-like domains in humans show significantly

56 indicate that 1C3 inhibits clustering of the immunoglobulin-like domains of GPVI on collagen/CRPs, a

57 ARD) is responsible for interacting with the immunoglobulin-like domains of MALT1.

58 e crystal structures of the first and second immunoglobulin-like domains of the Drosophila type IIa r

59 ns to investigate how misfolding between the immunoglobulin-like domains of titin is prevented.

60 Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) marks inte

61 e complex shows how AlkC uses unique HLR and immunoglobulin-like domains to induce a sharp kink in th

62 ar portion of CAR comprises two glycosylated immunoglobulin-like domains, D1 and D2.

63 The extracellular domain of Tvc contains two immunoglobulin-like domains, IgV and IgC, which presumab

64 , both elastin and HTE bind to the same LigB immunoglobulin-like domains, including LigBCon4, LigBCen

65 arge modular protein composed mainly of many immunoglobulin-like domains, is a potent cross-linker of

66 spite previous assignment to the C2 class of immunoglobulin-like domains, the structure of IgD1 revea

67 Leucine-rich repeats and immunoglobulin-like domains-1 (LRIG1) is a transmembrane

68 , heparanase 2, and leucine-rich repeats and immunoglobulin-like domains-2 (LRIG2), which is mutated

69 titin and most likely involves unfolding of immunoglobulin-like domains.

70 riking resemblance to the all-beta Greek key immunoglobulin-like domains.

71 istinctive bend between the second and third immunoglobulin-like domains.

72 n, the crystal structure of the CD8alphabeta immunoglobulin-like ectodomains were determined in compl

73 transmembrane protein, is composed of three immunoglobulin-like extracellular loops as well as a cyt

74 ment of FLNa containing Ig repeat 10 or with immunoglobulin-like filamin A repeat (IgFLNa)10 alone.

75 6IIe mutation maps within a highly conserved immunoglobulin-like fold (Ig10 domain) located in the sp

76 gy, consisting of two domains: an incomplete immunoglobulin-like fold (pilin body) and an N-terminal

77 N domain resolved to 2.0 A reveals a variant immunoglobulin-like fold and potential heparin-binding s

78 antigenic motifs in a single-domain chimeric immunoglobulin-like fold generated a vaccine that greatl

79 na by NMR and shown that it adopts a type of immunoglobulin-like fold not previously reported in lowe

80 ZP-N region, the ZP-C region also adopts an immunoglobulin-like fold, despite sharing no sequence ho

81 Each of these domains has an immunoglobulin-like fold, frequently found in cell attac

82 a pilus subunit to complement its incomplete immunoglobulin-like fold.

83 n of similar size, each featuring a variable immunoglobulin-like fold.

84 and carboxy-terminal domains of E2 each form immunoglobulin-like folds, consistent with the receptor

85 HSP27 and alphaB-crystallin associated with immunoglobulin-like (Ig) domain-containing regions, but

86 ers, is built from approximately 300 regular immunoglobulin-like (Ig) domains and FN-III repeats.

87 Immunoglobulin-like (Ig) domains are a widely expanded s

88 e ectodomain of neogenin is composed of four immunoglobulin-like (Ig) domains followed by six fibrone

89 Kettin is a large actin-binding protein with immunoglobulin-like (Ig) repeats, which is associated wi

90 elasticity; secondary structures of titin's immunoglobulin-like (Ig-) and fibronectin type III-like

91 Tricellulin and immunoglobulin-like (Ig-like) domain containing receptor

92 terminal actin-binding domain followed by 24 immunoglobulin-like (IgFLN) domains and we find that mig

93 transmission, are derived from extracellular immunoglobulin-like (IgL) domains and cytoplasmic immuno

94 B7-H1 is an immunoglobulin-like immune suppressive molecule broadly

95 ) disease, and more recently the killer cell immunoglobulin-like (KIR) locus has been implicated in d

96 for NK cell inhibition via inhibitory killer immunoglobulin-like (KIR) receptors and interrupts their

97 (Sn, Siglec-1, CD169), a sialic acid-binding immunoglobulin-like lectin (Siglec) expressed on subsets

98 Sialic acid-binding, immunoglobulin-like lectin (Siglec) F is a glycan-bindin

99 CD33 is a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family of inhibitory

100 the expression levels of sialic acid-binding immunoglobulin-like lectin (siglec) ligands.

101 CD22 is a sialic acid-binding immunoglobulin-like lectin (Siglec) that is highly expre

102 D22 is a B cell-specific sialic acid-binding immunoglobulin-like lectin (Siglec) whose function as a

103 Sialic acid-binding immunoglobulin-like lectin (Siglec)-8 is a cell-surface

104 Sialic acid-binding immunoglobulin-like lectin (Siglec)-8 is expressed on hu

105 Sialic acid-binding immunoglobulin-like lectin (Siglec)-F is a proapoptotic

106 responses by binding to sialic acid-binding immunoglobulin-like lectin 5 (Siglec-5), an inhibitory r

107 e expression of CCR3 and sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8).

108 l differentiation marker sialic acid-binding immunoglobulin-like lectin F and overproduced TNF and IL

109 crophages (AMs; CD11c(+) sialic acid-binding immunoglobulin-like lectin F(+)) in vivo and likewise de

110 mbrane protein CD33 is a sialic acid-binding immunoglobulin-like lectin that regulates innate immunit

111 Activation of sialic-acid-binding immunoglobulin-like lectin-G (Siglec-G) by noninfectious

112 y on 2 families of GBPs, sialic acid-binding immunoglobulin-like lectins (siglecs) and selectins, tha

113 Sialic acid-binding immunoglobulin-like lectins (siglecs) are predominately

114 e CD33-related subset of sialic acid-binding immunoglobulin-like lectins (Siglecs) consists of immuno

115 rom the siglec family of sialic acid-binding immunoglobulin-like lectins, for the glycosaminoglycan-b

116 We report that certain Sialic-acid-binding immunoglobulin-like-lectins (siglecs) are expressed in h

117 Leptospira immunoglobulin-like (Lig) proteins including LigA and Li

118 lement regulators is mediated by leptospiral immunoglobulin-like (Lig) proteins, previously shown to

119 For example, the leptospiral immunoglobulin-like (Lig) repeat proteins are dramatical

120 ation by dimerization of the membrane-distal immunoglobulin-like loop and a C-terminal postsynaptic d

121 Full-length 7d-VCAM-1, with seven immunoglobulin-like modules, contains integrin-binding s

122 d a prolonged half-life characteristic of an immunoglobulin-like molecule.

123 novel recognition mechanism for collagen by immunoglobulin-like motifs.

124 LigB (Leptospiral immunoglobulin-like protein B) contributes to the bindin

125 Nephrin, an immunoglobulin-like protein essential for the function o

126 the leucine-rich repeat (LRR) and bacterial immunoglobulin-like protein families.

127 ly, we and others have shown that Leptospira immunoglobulin-like proteins (Lig) of Leptospira spp. bi

128 cloning and characterization of leptospiral immunoglobulin-like proteins LigA and LigB of Leptospira

129 Pathogenic Leptospira spp. express immunoglobulin-like proteins, LigA and LigB, which serve

130 , NK cells that express an inhibitory killer immunoglobulin-like receptor (iKIR) for which the respec

131 The activating killer-cell immunoglobulin-like receptor (KIR) 2DS1 has ligand speci

132 atural killer (NK) cell receptor, the killer immunoglobulin-like receptor (KIR) 3DS1, and its presume

133 ow that the number of activating killer cell immunoglobulin-like receptor (KIR) copies in rhesus monk

134 The killer immunoglobulin-like receptor (KIR) gene cluster shows ex

135 tion (PCR) assays to compare NKG2 and killer immunoglobulin-like receptor (KIR) gene expression in NK

136 in the centromeric motif of the killer cell immunoglobulin-like receptor (KIR) gene family.

137 analyzed the influence of donor killer-cell immunoglobulin-like receptor (KIR) gene haplotypes on th

138 Killer-cell immunoglobulin-like receptor (KIR) genes form a diverse,

139 Combinations of HLA and killer cell immunoglobulin-like receptor (KIR) genes have been assoc

140 played by the inherited repertoire of killer immunoglobulin-like receptor (KIR) genes therefore may i

141 Killer immunoglobulin-like receptor (KIR) genes vary considerab

142 killer (NK) receptors, in particular, killer immunoglobulin-like receptor (KIR) KIR3DL2, a receptor f

143 A alleles and their natural killer (NK) cell immunoglobulin-like receptor (KIR) ligands.

144 class I ligands for donor inhibitory killer immunoglobulin-like receptor (KIR) receptors, as predict

145 The killer cell immunoglobulin-like receptor (KIR) repertoire of natural

146 tural killer (NK) cells that use killer-cell immunoglobulin-like receptor (KIR) to recognize the feta

147 Here, using a killer-cell immunoglobulin-like receptor (KIR) transgenic murine mod

148 cell alloreactivity mediated by killer cell immunoglobulin-like receptor (KIR)-HLA interactions may

149 ations before 2004, patient C2C2 killer cell immunoglobulin-like receptor (KIR)-ligand phenotype, and

150 explore the association between killer cell immunoglobulin-like receptor (KIR)/HLA and human immunod

151 Furthermore, killer immunoglobulin-like receptor (KIR)/KIR-ligand mismatch i

152 The leukocyte immunoglobulin-like receptor (LILR) A3 is a member of th

153 d myelomonocytic cells, CD94/NKG2, leukocyte immunoglobulin-like receptor (LILR), and killer immunogl

154 Paired immunoglobulin-like receptor (PILR) alpha is an inhibito

155 B2 (LILRB2) and its mouse orthologue paired immunoglobulin-like receptor (PIRB) are receptors for se

156 ally unrelated cell surface receptor, paired immunoglobulin-like receptor (PirB).

157 receptor B1 (LILRB1) or leucocyte-associated immunoglobulin-like receptor 1 (LAIR1).

158 or lacking the inhibitory receptor leukocyte immunoglobulin-like receptor 1 (LIR1) were differentiall

159 but how HLA class I (HLA-I) and killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) polymorphism

160 ic function associated with decreased killer immunoglobulin-like receptor 3DL1 expression.

161 ogens are specifically detected by leukocyte immunoglobulin-like receptor A2 (LILRA2), an orphan acti

162 NKp44 expression, and remarkable killer cell immunoglobulin-like receptor acquisition.

163 ssion of inhibitory receptors such as paired immunoglobulin-like receptor B (PIR-B) and their functio

164 d the role of the inhibitory receptor paired immunoglobulin-like receptor B (PIR-B) in the regulation

165 investigate the potential function of paired immunoglobulin-like receptor B (PIR-B), also known as le

166 Here we show that the paired immunoglobulin-like receptor B (PirB) negatively regulat

167 Here, we demonstrate that Paired-immunoglobulin-like receptor B (PirB), a major histocomp

168 xpression cloning, we have found that paired immunoglobulin-like receptor B (PirB), which has been im

169 We report that murine PirB (paired immunoglobulin-like receptor B) and its human ortholog L

170 h either the Nogo receptor complex or paired immunoglobulin-like receptor B.

171 a subset of RIFINs binds to either leucocyte immunoglobulin-like receptor B1 (LILRB1) or leucocyte-as

172 for trophoblast HLA-G stimulating leukocyte immunoglobulin-like receptor B1 receptors on decidual le

173 e immune-inhibitory receptor human leukocyte immunoglobulin-like receptor B2 (LILRB2) and its mouse o

174 yelomonocytic HLA class I receptor leukocyte immunoglobulin-like receptor B2 (LILRB2; ILT4), while bi

175 B) and its human ortholog LilrB2 (leukocyte immunoglobulin-like receptor B2), present in human brain

176 ng positions 9, 99, 116, and 156, and killer immunoglobulin-like receptor binding position 77 of HLA-

177 dendritic cell receptors from the leukocyte immunoglobulin-like receptor family.

178 ents (n=222) and controls (n=191) for killer immunoglobulin-like receptor gene polymorphisms did not

179 important for NK cell function, killer cell immunoglobulin-like receptor inhibitory signaling affect

180 s knockdown of its receptor, the killer cell immunoglobulin-like receptor KIR3DL2, on human astrocyte

181 ors for improved outcome were missing killer immunoglobulin-like receptor ligand (PFS and OS), human

182 1/5-positive granulocytes and missing killer immunoglobulin-like receptor ligand as positive independ

183 he model for OS also included missing killer immunoglobulin-like receptor ligand, human antimouse ant

184 ns (Rho-GTPase-activing protein 5, leukocyte immunoglobulin-like receptor subfamily A member 4 precur

185 al regulatory protein) and LILRB1 (leukocyte immunoglobulin-like receptor subfamily B member 1) showi

186 receptor B (PIR-B), also known as leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB

187 9x10(-16); R(2)=0.02) and with the leukocyte immunoglobulin-like receptor subfamily B member 5 (LILRB

188 ucts (RAGE) is an ubiquitous, transmembrane, immunoglobulin-like receptor that exists in multiple iso

189 NK cells predominately expressed killer cell immunoglobulin-like receptor, and self-killer cell immun

190 feron gamma receptor 2 (IFNGR2); killer cell immunoglobulin-like receptor, three domain, long cytopla

191 coprotein VI (GPVI) and leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1).

192 d on days -6 through -2), followed by killer immunoglobulin-like receptor-human leukocyte antigen (KI

193 lobulin-like receptors, a fraction of killer immunoglobulin-like receptor-positive-expressing cells t

194 netic studies suggest a role for killer cell immunoglobulin-like receptor/HLA (KIR/HLA) compound geno

195 Killer cell immunoglobulin like receptors (KIRs) are a family of typ

196 iller (NK) cells and their activating killer immunoglobulin-like receptors (aKIRs) influence the immu

197 omodulatory CD33-related sialic acid-binding immunoglobulin-like receptors (CD33rSiglecs) and maximum

198 tor function depends on specific killer-cell immunoglobulin-like receptors (KIR) and HLA interactions

199 mans, interactions between inhibitory killer immunoglobulin-like receptors (KIR) and human MHC (HLA)

200 For primate NK cells, the killer-cell immunoglobulin-like receptors (KIR) are a variable and r

201 Killer immunoglobulin-like receptors (KIR) are expressed by nat

202 -B27 and immune receptors such as the killer immunoglobulin-like receptors (KIR) found on a range of

203 ting and inhibitory forms of the killer cell immunoglobulin-like receptors (KIR) in natural killer (N

204 The inhibitory function of killer cell immunoglobulin-like receptors (KIR) that bind HLA-C and

205 function can be modulated by the killer cell immunoglobulin-like receptors (KIR) which interact with

206 ally mediated through binding of killer-cell immunoglobulin-like receptors (KIR) with HLA class I lig

207 human leukocyte antigens (HLA), killer-cell immunoglobulin-like receptors (KIR), major histocompatib

208 nate immunity as ligands for the killer cell immunoglobulin-like receptors (KIR), which modulate natu

209 against HIV by interacting with killer cell immunoglobulin-like receptors (KIR).

210 cells are regulated, in part, by killer cell immunoglobulin-like receptors (KIR).

211 lex (MHC) class I, including the killer cell immunoglobulin-like receptors (KIR).

212 ted by inhibitory and activating killer cell immunoglobulin-like receptors (KIR).

213 n interaction between inhibitory killer cell immunoglobulin-like receptors (KIRs) and HLA class I lig

214 Interactions between killer cell immunoglobulin-like receptors (KIRs) and human leukocyte

215 oreactivity, determined by donor killer-cell immunoglobulin-like receptors (KIRs) and recipient HLA,

216 lex (MHC) class I, including the killer cell immunoglobulin-like receptors (KIRs) and the C-type lect

217 wo such families of NK receptors, the killer immunoglobulin-like receptors (KIRs) and the killer cell

218 Epistatic interactions between killer cell immunoglobulin-like receptors (KIRs) and their cognate H

219 pon diverse interactions between killer cell immunoglobulin-like receptors (KIRs) and their HLA class

220 Killer cell immunoglobulin-like receptors (KIRs) and their HLA ligan

221 ls are functionally regulated by killer cell immunoglobulin-like receptors (KIRs) and their interacti

222 lymorphic sets of molecules: the killer-cell immunoglobulin-like receptors (KIRs) and their major his

223 Killer immunoglobulin-like receptors (KIRs) are a family of reg

224 Human killer cell immunoglobulin-like receptors (KIRs) are distinguished b

225 Because the HLA-C locus and killer cell immunoglobulin-like receptors (KIRs) are of key importan

226 ules as ligands to NK cell inhibitory killer immunoglobulin-like receptors (KIRs) as a means of immun

227 Killer immunoglobulin-like receptors (KIRs) bind human leukocyt

228 attenuated by ligation of inhibitory killer immunoglobulin-like receptors (KIRs) by HLA class I mole

229 Strikingly, expression of killer-cell immunoglobulin-like receptors (KIRs) did not educate fet

230 e the crucial role of activating killer-cell immunoglobulin-like receptors (KIRs) in NK cell-mediated

231 role of NK cells expressing specific killer immunoglobulin-like receptors (KIRs) in the control of h

232 ct by careful mismatching on the killer-cell immunoglobulin-like receptors (KIRs) ligand.

233 Killer immunoglobulin-like receptors (KIRs) on natural killer (

234 been attributed to mismatches between killer immunoglobulin-like receptors (KIRs) on NK cells and the

235 Killer immunoglobulin-like receptors (KIRs) play an essential r

236 Killer cell immunoglobulin-like receptors (KIRs) play an important r

237 Killer immunoglobulin-like receptors (KIRs) regulate natural ki

238 ity and reproduction are diverse killer cell immunoglobulin-like receptors (KIRs) that recognize poly

239 Killer-cell immunoglobulin-like receptors (KIRs) that regulate natur

240 asing age, T cells gain expression of killer immunoglobulin-like receptors (KIRs) that transmit negat

241 Interactions of killer cell immunoglobulin-like receptors (KIRs) with major histocom

242 The engagement of natural killer cell immunoglobulin-like receptors (KIRs) with their target l

243 se receptor families such as the killer cell immunoglobulin-like receptors (KIRs), and (ii) indirect

244 cluding the activating and inhibitory killer immunoglobulin-like receptors (KIRs), and human leukocyt

245 iller (NK) cells possess little or no killer immunoglobulin-like receptors (KIRs), high interferon-ga

246 Killer cell immunoglobulin-like receptors (KIRs), via interaction wi

247 re a group of genes encoding the killer cell immunoglobulin-like receptors (KIRs), which have known a

248 lls by both activating and inhibitory killer immunoglobulin-like receptors (KIRs).

249 ession pattern of immunomodulatory leukocyte-immunoglobulin-like receptors (LILR) and a strong and se

250 Leukocyte Immunoglobulin-like receptors (LILR) are innate immune r

251 the activating receptor NKp46 and the killer immunoglobulin-like receptors 2DL1/S1 and 3DL1, reduced

252 he association of natural killer cell killer immunoglobulin-like receptors and human leukocyte antige

253 e frequently expressed educating killer cell immunoglobulin-like receptors compared with NK cells in

254 closely monitored by NK cells, whose killer immunoglobulin-like receptors encode MHC-I-specific acti

255 ivity in eosinophils was regulated by paired immunoglobulin-like receptors PIR-A and PIR-B.

256 rus binding to a sialic acid receptor and to immunoglobulin-like receptors used by most other enterov

257 globulin-like receptor, and self-killer cell immunoglobulin-like receptors were required for robust I

258 )M-CSFR(+)) showed more expression of killer immunoglobulin-like receptors, a fraction of killer immu

259 eptors, mannose-binding lectin, CD14, killer immunoglobulin-like receptors, and matrix metalloprotein

260 immune-cell-specific genes, including novel immunoglobulin-like receptors, and neofunctionalization

261 ontains the allelic sequences of killer-cell immunoglobulin-like receptors, IPD-MHC, a database of se

262 ontains the allelic sequences of Killer-cell Immunoglobulin-like Receptors, IPD-MHC, is a database of

263 uch as human leukocyte antigens, killer-cell immunoglobulin-like receptors, major histocompatibility

264 d cell surface receptors, such as the killer immunoglobulin-like receptors.

265 ally downregulates disease-associated killer immunoglobulin-like receptors.

266 igand-receptor interactions with killer-cell immunoglobulin-like receptors.

267 The interaction required FlnA immunoglobulin-like repeat 20 and the tip of PACSIN2 F-B

268 hy, we show how the CFTR N terminus binds to immunoglobulin-like repeat 21 of filamin A (FlnA-Ig21).

269 lnA-Syk interaction, as Syk binds to FlnA at immunoglobulin-like repeat 5.

270 ntains the partial eleventh and full twelfth immunoglobulin-like repeats (LigBCen2R) and 47 amino aci

271 CFTR N terminus also binds to several other immunoglobulin-like repeats from filamin A in vitro.

272 he Lig surface proteins containing imperfect immunoglobulin-like repeats that are shared or differ be

273 tilization of different surfaces of a single immunoglobulin-like scaffold to generate binding protein

274 The MSP domain is a conserved immunoglobulin-like structure that is important for C. e

275 We show that the CALX1.1-CBD2 is an immunoglobulin-like structure, similar to mammalian NCX1

276 the full activation of TAMs and that soluble immunoglobulin-like TAM domains act as specific ligand a

277 FbsC, which bears two bacterial immunoglobulin-like tandem repeat domains and a C-termin

278 ibits substantially increased binding to the immunoglobulin-like transcript (ILT) receptor 4, an inhi

279 The inhibitory receptor immunoglobulin-like transcript (ILT)-2 is expressed on a

280 Cs) were identified and expressions of CD86, immunoglobulin-like transcript 3 (ILT3) and ILT4 were an

281 regulation of the surface receptor ILT3, the immunoglobulin-like transcript 3 that is normally found

282 ) ) and regulatory dendritic cells (DCregs) (immunoglobulin-like transcript 3(+) /4(+) ); (2) liver b

283 how that primary human neutrophils expressed immunoglobulin-like transcript 4 (ILT4) inhibitory recep

284 lecule B*3503 binds with greater affinity to immunoglobulin-like transcript 4 (ILT4), an inhibitory M

285 Interaction of HLA-G with its receptor, immunoglobulin-like transcript 4 on dendritic cells (DCs

286 We examined expression of HLA-G, immunoglobulin-like transcript 4, other immune regulator

287 ression of tolerogenic molecules, HLA-G, and immunoglobulin-like transcript 4.

288 DCs specifically express an orphan receptor, immunoglobulin-like transcript 7 (ILT7).

289 sessed expression of PIR-B human homologues (immunoglobulin-like transcript [ILT]-2 and ILT-3) in col

290 Immunoglobulin-like transcripts are a family of inhibito

291 imeric structure, partly held together by an immunoglobulin-like trimerization domain that is C-termi

292 Recently, paired immunoglobulin-like type 2 receptor (PILRalpha) was iden

293 eater degree with the gB receptor the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) th

294 Paired immunoglobulin-like type 2 receptor alpha (PILRalpha), a

295 herpesvirus entry mediator (HVEM) or paired immunoglobulin-like type 2 receptor alpha (PILRalpha).

296 Paired immunoglobulin-like type 2 receptors (PILRs) inhibitory

297 herpesvirus entry mediator (HVEM), or paired immunoglobulin-like type-2 receptor alpha (PILRalpha).

298 The PtdSer-binding activity of the immunoglobulin-like variable (IgV) domain is essential f

299 re composed of alphabeta subunits displaying immunoglobulin-like variable domains that recognize pept

300 The structure of TLT-1 is similar to other immunoglobulin-like variable domains, particularly those